haloperidol has been researched along with Inadequate Sleep in 11 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Withdrawal of the narcolepsy treatment and initiation of haloperidol 1 mg/day (the only antipsychotic treatment she could tolerate) improved the delusions, hallucinations and dysphoria but worsened the narcolepsy symptoms." | 3.85 | Narcolepsy-cataplexy and psychosis: a case study. ( Arango-Lopez, C; Canellas-Dols, F; Delgado, C; Peraita-Adrados, R, 2017) |
| " The volunteers who were given haloperidol combined with sleep deprivation exhibited an elevation of the duration and density of the STW, without significant alterations of the other REM sleep phasic phenomena such as rapid eye movement." | 2.70 | Sawtooth waves during REM sleep after administration of haloperidol combined with total sleep deprivation in healthy young subjects. ( Peres, CA; Pinto, LR; Remesar-Lopez, AJ; Russo, RH; Tufik, S, 2002) |
| "Recently, we described catalepsy induced in Wistar rats by somatostatin antagonist, cyclosomatostatin (cSST); this model simulates such a disease-associated abnormality as a fall in brain somatostatin levels." | 1.48 | Cyclosomatostatin- and haloperidol-induced catalepsy in Wistar rats: Differential responsiveness to sleep deprivation. ( Frenkel, DD; Gorev, NP; Ionov, ID; Pushinskaya, II, 2018) |
| "Our results indicate that REM sleep deprivation enhances the SMB induced by the daily administration of d-amphetamine and suggest the involvement of D1 DA receptors in the mechanism underlying the SMB." | 1.30 | Effects of REM sleep deprivation on the d-amphetamine-induced self-mutilating behavior. ( Drucker-Colín, R; Lara-Lemus, A; Méndez-Franco, J; Palomero-Rivero, M; Pérez de la Mora, M, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Canellas-Dols, F | 1 |
| Delgado, C | 1 |
| Arango-Lopez, C | 1 |
| Peraita-Adrados, R | 1 |
| Ionov, ID | 1 |
| Pushinskaya, II | 1 |
| Gorev, NP | 1 |
| Frenkel, DD | 1 |
| Proença, MB | 1 |
| Dombrowski, PA | 1 |
| Da Cunha, C | 1 |
| Fischer, L | 1 |
| Ferraz, AC | 1 |
| Lima, MM | 2 |
| Andersen, ML | 1 |
| Reksidler, AB | 1 |
| Silva, A | 1 |
| Zager, A | 1 |
| Zanata, SM | 1 |
| Vital, MA | 1 |
| Tufik, S | 3 |
| Wright, JB | 1 |
| Lara-Lemus, A | 1 |
| Pérez de la Mora, M | 1 |
| Méndez-Franco, J | 1 |
| Palomero-Rivero, M | 1 |
| Drucker-Colín, R | 1 |
| Skurikhin, EG | 1 |
| Dygai, AM | 1 |
| Suslov, NI | 1 |
| Provalova, NV | 1 |
| Zyuz'kov, GN | 1 |
| Gol'dberg, ED | 1 |
| Pinto, LR | 1 |
| Peres, CA | 1 |
| Russo, RH | 1 |
| Remesar-Lopez, AJ | 1 |
| Fratta, W | 1 |
| Collu, M | 1 |
| Martellotta, MC | 1 |
| Pichiri, M | 1 |
| Muntoni, F | 1 |
| Gessa, GL | 1 |
| Eichelman, B | 1 |
1 review available for haloperidol and Inadequate Sleep
| Article | Year |
|---|---|
The catecholamines and aggressive behavior.
Topics: Aggression; Amphetamine; Anger; Animals; Behavior, Animal; Brain Stem; Catecholamines; Dihydroxyphen | 1973 |
1 trial available for haloperidol and Inadequate Sleep
| Article | Year |
|---|---|
Sawtooth waves during REM sleep after administration of haloperidol combined with total sleep deprivation in healthy young subjects.
Topics: Adult; Dopamine Antagonists; Double-Blind Method; Haloperidol; Humans; Male; Polysomnography; Sleep | 2002 |
9 other studies available for haloperidol and Inadequate Sleep
| Article | Year |
|---|---|
Narcolepsy-cataplexy and psychosis: a case study.
Topics: Adolescent; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compound | 2017 |
Cyclosomatostatin- and haloperidol-induced catalepsy in Wistar rats: Differential responsiveness to sleep deprivation.
Topics: Animals; Antipsychotic Agents; Catalepsy; Dopamine Antagonists; Haloperidol; Immobilization; Injecti | 2018 |
Dopaminergic D2 receptor is a key player in the substantia nigra pars compacta neuronal activation mediated by REM sleep deprivation.
Topics: Animals; Corpus Striatum; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor An | 2014 |
Blockage of dopaminergic D(2) receptors produces decrease of REM but not of slow wave sleep in rats after REM sleep deprivation.
Topics: Analysis of Variance; Animals; Behavior, Animal; Dopamine Agonists; Dopamine Antagonists; Gene Expre | 2008 |
Changes of response to dopaminergic drugs in rats submitted to REM-sleep deprivation.
Topics: Adrenergic Agonists; Aggression; Animals; Apomorphine; Bromocriptine; Haloperidol; Humans; Male; Pir | 1981 |
Mania following sleep deprivation.
Topics: Adult; Bipolar Disorder; Chlorpromazine; Haloperidol; Humans; Male; Sleep Deprivation | 1993 |
Effects of REM sleep deprivation on the d-amphetamine-induced self-mutilating behavior.
Topics: Animals; Benzazepines; Central Nervous System Stimulants; Dextroamphetamine; Dopamine; Dopamine Anta | 1997 |
Role of the central nervous system in hemopoiesis regulation during experimental neuroses.
Topics: Animals; Brain Chemistry; Central Nervous System; Conflict, Psychological; Cyproheptadine; Disease M | 2001 |
Stress-induced insomnia: opioid-dopamine interactions.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Appetite | 1987 |